Lirexapride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLirexapride
Drug Alias NameJL-17454CHF-17454
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptorDopamine D2 receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiesi Farmaceutici SPA
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A